openPR Logo
Press release

Ischemic Heart Disease Market Based on Various Factors- Price Analysis, Supply Chain Analysis, Porters Five Force Analysis Etc.

03-27-2019 08:08 AM CET | Health & Medicine

Press release from: MarketResearchFuture

Ischemic heart Disease Market

Ischemic heart Disease Market

“The Middle East and Africa Ischemic heart disease Market Research Report - Forecast till 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.

King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), AstraZeneca (U.K.), Sanofi (France), Merck Sharp & Dohme Corp.(U.S.), AUM Cardiovascular (U.S.), HeartWare (U.S.), are some of the leading players at the cutting edge of the competition in the market of ischemic heart disease, The Middle East and Africa.

Download Free Sample Report @ https://www.marketresearchfuture.com/sample_request/2585

Ischemic Heart Disease, is a condition that affects the supply of blood to the heart. It is also known as coronary artery disease, in which blood vessels become narrowed or blocked owing to the deposition of cholesterol on their walls. Ischemic heart disease leads to disease such as stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Oxygen and nutrients are essential for proper function of the heart, but owing to this disease, there is the low supply of oxygen and nutrients to the heart muscles. This may eventually result in a portion of the heart being suddenly deprived of its blood supply leading to the death of that area of heart tissue, resulting in a heart attack. There is the huge demand of the ischemic heart disease treatment in the Middle East and Africa owing to the increase in disease related to heart. According to the report published by the Centers for Disease Control and Prevention (CDC), in 2016, ischemic heart disease is the one of the top ten leading causes of death in Saudi Arabia regions and account almost 6% death every year.

The Middle East and Africa Ischemic heart disease Market – Overview

The Middle East and Africa Ischemic heart disease market are showing the steady growth; mainly owing to increase in consumption of smoking, diabetes mellitus and cholesterol levels. There are few more factors which lead the occurrence of Ischemic heart disease, such as Hypertension, Genetic and hereditary factors, sedentary lifestyle, and Stress.

According to, Dubai Health Authority, Heart disease causes three in every 10 deaths in the UAE. Also, according to the Centers for Disease Control and Prevention (CDC), around 17.7 million people died with CVD, which hold 31% of all global deaths. Whereas in Saudi Arabia its holds 6% of total death. Companies are continually inventing new treatment to capture the Middle East and Africa market. Thus, players focusing more on educating the public about diseases related to heart, symptom, and precaution in order to develop their brand image and awareness within the region. In this regards, Hamad Medical Corporation, in September 2016, launched heart health campaign, with the aim to educate the public on how to recognize the signs and symptoms of a heart attack and advice on what to do if a heart attack is suspected. The company also educated the public on how to improve their heart health by providing information about heart conditions and the importance of maintaining a healthy heart. These activities help them to keep ahead with their competitor.

The Middle East and Africa Ischemic heart disease Market - Regional Analysis

According to the World Health Organization (WHO), in 2015, over 1.1 billion people were smoking tobacco, and male population consumes more in comparison to female. Although it is declining worldwide, but in many countries, the prevalence of tobacco smoking appears to be increasing, especially in the WHO Eastern Mediterranean Region and the African Region. The most affected countries in the Middle East are Egypt, Iran, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia (SAU), United Arab Emirates (UAE) and Yemen and in Africa Algeria, and Tunisia. World organization is more focused in order to provide funds to the countries of this region in order to improve the quality of life.

UAE is the largest market for ischemic heart disease in the entire Middle East and Africa market owing to the presence of huge population suffering with disease related to heart. The rest of Africa market is, however the fastest growing with a huge unmet medical need and high rate of tobacco and alcohol consumption which leads the incidence of many diseases. Moreover, the government of these countries are looking support from developed and developing nation in order to get effective and advanced treatment at lower cost. Companies are also looking forward to this market owing to the huge gap between demand and supply of the patients. According to the report published by the Centers for Disease Control and Prevention (CDC), in 2015, CDC has worked with the Kingdom of Saudi Arabia from 20 years, along with the Ministry of Health, WHO, local partners, and other U.S. Government agencies in reducing the impact of emerging diseases by building capacity in areas such as laboratory systems and epidemiology, strengthen immunization services, respond to public health emergencies, and conduct surveillance, surveys, and studies.

Report Details @ https://www.marketresearchfuture.com/reports/mea-ischemic-heart-disease-market-2585

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ischemic Heart Disease Market Based on Various Factors- Price Analysis, Supply Chain Analysis, Porters Five Force Analysis Etc. here

News-ID: 1673735 • Views: 187

More Releases from MarketResearchFuture

Water Based Acrylates Copolymer Rheology Modifiers Market Outlook 2019 Trend, Si …
Market Research Future (MRFR)’s team said, “Global Water Based Acrylates Copolymer Rheology Modifiers was valued at USD 365.6 million in 2016 and is predicted to grow at 4.35% CAGR to reach USD 471.9 million by the end of 2023. Water Based Acrylates Copolymer Rheology Modifiers are gaining importance in the global market with the increasing application in personal care and paints & coatings. Other applications including adhesive & sealants, pharmaceuticals,
Rheology Modifiers Market Size, Share, Industry Segments, Sales, Consumption, La …
The global rheology modifiers market is driven by the scope of its application in various sectors such as paints & coatings, cosmetics & personal care, adhesives & sealants, and others. Moreover, the paints & coatings segment is set to grow at a higher CAGR owing to the boundless use of adhesives in the sector. Rheology modifiers are agents used to produce inks, paints, and others. They are extensively used in end-use
Global Telemedicine Market size can reach USD 56,738.3, demonstrating a signific …
Global Telemedicine Market is segmented based on service type, component, deployment, application, and end-user. By service type, the market has been segmented into telenursing, tele pharmacy, teleradiology, tele dermatology, tele-oncology, others. By component, the market has been segmented into software and hardware. The software segment is further segmented into integrated software and standalone software. The hardware segment is further segmented into monitors and medical peripheral devices. By deployment, the market has
Global Clinical Data Analytics Market is expected to Rise up to USD 11,853.6 mil …
Global Clinical Data Analytics Market has been evaluated as a growing market and it is expected that the market will touch high growth figures. Increasing the technological advancements in mHealth and IoT and rising number of government initiatives are some of the factors driving this market. The Global Clinical Data Analytics Market is expected to reach USD 11,853.6 million in 2022. The Global Clinical data analytics market is expected to grow

All 5 Releases


More Releases for Ischemic

Global Ischemic Heart Disease Market Research and Forecast, 2018-2023
According to OMR analysis, the global ischemic heart disease market is estimated to grow at a significant CAGR during the forecast period(2018-2023). Various pivotal factors that are augmenting the ischemic heart disease market includes growing incidence and prevalence rate of hypertension, high cholesterol, diabetes, and obesity across the globe. Government funding for diagnosis, treatment and research and their initiative programs to increase the awareness toward disease is another major
Research report prospects the Ischemic Heart Disease Treatment Market
Ischemic heart disease blocks blood supply to the heart. It is also known as coronary artery disease. Blood vessels get blocked or narrowed due to cholesterol deposition on the walls. This decreases nutrients and oxygen supply to heart muscles, which is important for appropriate functioning of the heart. This results in a part of the heart being rapidly run down of its blood supply and causes death of heart tissues.
Global Ischemic Heart Disease Drugs Market Research Report 2017
Global Ischemic Heart Disease Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including AstraZeneca Bayer Actelion Bristol-Myers Squibb Boehringer Ingelheim ... On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Anti-dyslipidemic Drugs Calcium Channel Blockers Antithrombotic Agents ACE Inhibitors Vasodilators Beta-blockers On the basis on the end users/applications, this report focuses on the status and outlook for major
Ischemic Stroke - Pipeline Insight and Therapeutic Assessment 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Ischemic Stroke - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Ischemic Stroke. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265452 A comparative pipeline therapeutics assessment of Ischemic Stroke by development stage,
Ischemic Cerebral Stroke Market Outlook and Forecast up to 2024
Ischemic Cerebral Stroke Market: Overview Ischemic cerebral stroke occurs when blood vessels that supply blood to brain are blocked due to the formation of blood clots resulting in the corresponding loss of neurologic function. The symptoms of ischemic cerebral stroke complains include the abrupt onset of hemiparesis, quadriparesis and monoparesis, monocular visual loss, diplopia, visual field deficits, hemisensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia and decrease in the level
North America Leads the Ischemic Cerebral Stroke Market Followed by Europe Major …
Ischemic Cerebral Stroke Market: Overview Ischemic cerebral stroke occurs when blood vessels that supply blood to brain are blocked due to the formation of blood clots resulting in the corresponding loss of neurologic function. The symptoms of ischemic cerebral stroke complains include the abrupt onset of hemiparesis, quadriparesis and monoparesis, monocular visual loss, diplopia, visual field deficits, hemisensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia and decrease in the level